DELANEY MARK E
SEC CIK 1955265 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DGX | Quest Diagnostics | SVP, Chief Commercial Off | 10.3K | — | $2.30M | 31 | 2023-02-23 | 2026-07-28 |
Most active insiders at DGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Davis J. E. | CEO, Pres, Dir | — | $17.08M |
| 2 | Doherty Catherine T. | EVP, Regional Businesses | — | $6.96M |
| 3 | PREVOZNIK MICHAEL E | SVP, GC | — | $6.69M |
| 4 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | — | $2.17M |
| 5 | Plewman Patrick | SVP for Diagnostic Services | — | $2.03M |
| 6 | DELANEY MARK E | SVP, Chief Commercial Off | — | $1.86M |
| 7 | PFEIFFER GARY M | Dir | — | $270.3K |
| 8 | Gregg Vicky B | Dir | — | $239.7K |
| 9 | Lassiter Wright III | Dir | — | — |
| 10 | Deppe Michael J | SVP, CAO, Corp. Ctrl | — | — |
Transactions 31
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-07-29 17:04 | 2026-07-28 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | S - Sale | $235.18 | -1,600 | 10.3K | -13% | -$376.3K |
| 2026-07-27 16:32 | 2026-07-22 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | L - Small Acq | $206.81 | +34 | 11.9K | +0.3% | +$7,031 | |
| 2026-04-24 18:23 | 2026-04-20 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | L - Small Acq | $194.70 | +37 | 11.9K | +0.3% | +$7,204 | |
| 2026-03-06 | 2026-03-04 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | A - Grant | $204.86 | +5,682 | 14.2K | +67% | +$1.16M | |
| 2026-03-06 | 2026-03-04 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | F - Tax | $204.86 | -2,326 | 11.9K | -16% | -$476.5K | |
| 2026-03-04 | 2026-03-02 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | F - Tax | $204.86 | -188 | 8,508 | -2% | -$38.5K | |
| D | 2026-02-20 | 2026-02-18 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | A - Grant | $0.00 | +1,586 | 9,116 | +21% | $0 |
| DM | 2026-02-20 | 2026-02-18 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | F - Tax | $208.41 | -435 | 8,911 | -5% | -$90.7K |
| D | 2026-02-20 | 2026-01-28 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | L - Small Acq | $183.51 | +15 | 8,696 | +0.2% | +$2,753 |
| DM | 2025-11-20 | 2025-11-18 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | M - OptEx | $144.46 | +7,946 | 15.5K | +106% | +$1.15M |
| D | 2025-11-20 | 2025-11-18 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | S - Sale+OE | $187.35 | -7,946 | 7,530 | -51% | -$1.49M |
| 2025-10-24 | 2025-10-21 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | A - Grant | $189.08 | +15 | 7,530 | +0.2% | +$2,836 | |
| 2025-07-25 | 2025-07-21 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | L - Small Acq | $167.49 | +17 | 7,515 | +0.2% | +$2,847 | |
| M | 2025-05-14 | 2025-05-12+ | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | S - Sale | $175.51 | -1,748 | 7,498 | -19% | -$306.8K |
| 2025-05-02 | 2025-04-21 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | L - Small Acq | $164.42 | +25 | 9,246 | +0.3% | +$4,110 | |
| 2025-03-28 | 2025-03-26 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | F - Tax | $166.71 | -256 | 9,221 | -3% | -$42.7K | |
| 2025-03-05 | 2025-03-04 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | A - Grant | $173.74 | +5,317 | 11.3K | +89% | +$923.8K | |
| 2025-03-05 | 2025-03-04 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | F - Tax | $173.74 | -1,823 | 9,477 | -16% | -$316.7K | |
| 2025-02-28 | 2025-02-26 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | F - Tax | $171.75 | -214 | 5,983 | -3% | -$36.8K | |
| 2025-02-21 | 2025-02-19 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | F - Tax | $169.71 | -242 | 6,197 | -4% | -$41.1K | |
| D | 2025-02-14 | 2025-02-12 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | A - Grant | $0.00 | +1,815 | 6,439 | +39% | $0 |
| 2025-02-07 | 2025-02-05 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | S - Sale | $164.30 | -403 | 4,624 | -8% | -$66.2K | |
| 2025-01-31 | 2025-01-29 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | L - Small Acq | $158.03 | +4 | 5,027 | +0.1% | +$632.12 | |
| 2024-10-25 | 2024-10-21 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | L - Small Acq | $149.39 | +4 | 5,023 | +0.1% | +$597.56 | |
| 2024-07-26 | 2024-07-24 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | S - Sale | $143.08 | -420 | 5,019 | -8% | -$60.1K | |
| 2024-07-26 | 2024-07-22 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | L - Small Acq | $146.98 | +6 | 5,439 | +0.1% | +$881.88 | |
| 2024-03-28 | 2024-03-26 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | F - Tax | $128.11 | -170 | 5,433 | -3% | -$21.8K | |
| 2024-03-01 | 2024-02-28 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | F - Tax | $126.36 | -225 | 5,603 | -4% | -$28.4K | |
| D | 2024-02-16 | 2024-02-14 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | A - Grant | $0.00 | +2,348 | 5,828 | +67% | $0 |
| 2023-03-27 | 2023-03-24 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | F - Tax | $134.25 | -170 | 3,480 | -5% | -$22.8K | |
| D | 2023-02-27 | 2023-02-23 | DGX | Quest Diagnostics | DELANEY MARK E | SVP, Chief Commercial Off | A - Grant | $0.00 | +1,919 | 3,650 | +111% | $0 |
Purchase Sale Sale after option exercise All abbreviations